| 
 2003 Journal Article Abnormalities of the PTH-vitamin D axis and bone turnover markers in children, adolescents and adults with cystic fibrosis: comparison with healthy controlsGreer, Ristan M., Buntain, Helen M., Potter, Julia M., Wainwright, Claire E., Wong, Joseph C., O'Rourke, Peter K., Francis, Paul W., Bell, Scott C. and Batch, Jennifer A. (2003). Abnormalities of the PTH-vitamin D axis and bone turnover markers in children, adolescents and adults with cystic fibrosis: comparison with healthy controls. Osteoporosis International, 14 (5), 404-411. doi: 10.1007/s00198-003-1388-1  | 
              
| 
 2002 Journal Article Novel application of biological glue in the management of a complicated pneumothorax in cystic fibrosisGarske, Luke A., Tam, Robert K.W., Windsor, Morgan F. and Bell, Scott C. (2002). Novel application of biological glue in the management of a complicated pneumothorax in cystic fibrosis. Pediatric Pulmonology, 34 (2), 138-140. doi: 10.1002/ppul.10112  | 
              
| 
 2002 Journal Article Effect of long term treatment with azithromycin on disease parameters in cystic fibrosis: A randomised trialWolter, J., Seeney, S., Bell, S., Bowler, S., Masel, P. and McCormack, J. (2002). Effect of long term treatment with azithromycin on disease parameters in cystic fibrosis: A randomised trial. Thorax, 57 (3), 212-216. doi: 10.1136/thorax.57.3.212  | 
              
| 
 2002 Journal Article Effect of long term treatment with azithromycin on disease parameters in cystic fibrosis: a randomised trialWolter, J., Seeney, S., Bell, S., Bowler, S., Masel, P. and McCormack, J. (2002). Effect of long term treatment with azithromycin on disease parameters in cystic fibrosis: a randomised trial. Thorax, 57 (3), 212-216. doi: 10.1136/thorax.57.3.212  | 
              
| 
 2002 Conference Publication Prevalence of cystic fibrosis-related diabetes (CFRD) in an adult cystic fibrosis (CF) unitMatson, A., Walker, F., Matson, K. and Bell, S. C. (2002). Prevalence of cystic fibrosis-related diabetes (CFRD) in an adult cystic fibrosis (CF) unit. TSANZ Annual Scientific Meeting, Cairns, 22-27 Mar, 2002. Carlton: Blackwell Asia.  | 
              
| 
 2002 Journal Article Nebulised dornase alpha: adherence in adults with cystic fibrosisBurrows, J. A., Bunting, J. P., Masel, P. J. and Bell, S. C. (2002). Nebulised dornase alpha: adherence in adults with cystic fibrosis. Journal of Cystic Fibrosis, 1 (4), 255-259. doi: 10.1016/S1569-1993(02)00095-4  | 
              
| 
 2002 Conference Publication Uncoupled bone turnover in cystic fibrosis: bone markers and the PTH-vitamin D axisGreer, R. M., Buntain, H., Wainwright, C. E., Potter, J. M., Munns, C., O'Rourke, P., Francis, P., Batch, J. and Bell, S. C. (2002). Uncoupled bone turnover in cystic fibrosis: bone markers and the PTH-vitamin D axis. 16th Annual North American Cystic Fibrosis Conference, Louisiana, 3-6 October, 2002. New York: Wiley-Liss. doi: 10.1002/ppul.70012  | 
              
| 
 2002 Conference Publication Puberty and bone mineral accrual in cystic fibrosisBuntain, H. M., Greer, R. M., Batch, J., Wong, J., Lewindon, P., Schluter, P., Bell, S. C., Potter, J. and Wainwright, C. E. (2002). Puberty and bone mineral accrual in cystic fibrosis. TSANZ 2002 Annual Scientific Meeting. Respirology, Cairns, QLD, Australia, 22-27 March 2002. Carlton, VIC, Australia: Wiley-Blackwell Publishing Asia. doi: 10.1111/j.1440-1843.2004.supp_2.x  | 
              
| 
 2002 Conference Publication Age appropriate pubertal development in cystic fibrosisBuntain, H., Greer, R. M., Schluter, P., Batch, J., Bell, S. C. and Wainwright, C. E. (2002). Age appropriate pubertal development in cystic fibrosis. The 16th Annual North American Cystic Fibrosis Conference, Louisiana, 3-6 October, 2002. New York: Wiley-Liss. doi: 10.1002/ppul.70012  | 
              
| 
 2002 Conference Publication Rifampicin and fusidic acid reduces the frequency of MRSA isolation and need for intravenous antibiotics in adult patients with cystic fibrosis and chronic MRSA infectionGarske, L., Bunting, J., Franks, C., Masel, P. and Bell, S. (2002). Rifampicin and fusidic acid reduces the frequency of MRSA isolation and need for intravenous antibiotics in adult patients with cystic fibrosis and chronic MRSA infection. TSANZ Annual Scientific Meeting, Cairns, 22-27 Mar, 2002. Carlton: Blackwell Asia.  | 
              
| 
 2002 Journal Article Pamidronate results in symptom control of hypertrophic pulmonary osteoarthropathy in cystic fibrosisGarske, L. A. and Bell, S. C. (2002). Pamidronate results in symptom control of hypertrophic pulmonary osteoarthropathy in cystic fibrosis. Chest, 121 (4), 1363-1364. doi: 10.1378/chest.121.4.1363  | 
              
| 
 2002 Conference Publication A study of the use of complementary and alternative medicines (CAM) in adults with cystic fibrosis (CF)Phillips, J., Bajramovic, J. and Bell, S. (2002). A study of the use of complementary and alternative medicines (CAM) in adults with cystic fibrosis (CF). TSANZ Annual Scientific Meeting, Cairns, 22-27 Mar, 2002. Carlton: Blackwell Asia.  | 
              
| 
 2002 Conference Publication Long-term treatment with azithromycin results in reduced ex-vivo inflammatory cytokine production in adults with cystic fibrosisBell, S. C., Seeney, S., Walmsley, K., Wolter, J. M., Bowler, S. D. and McCormack, J. G. (2002). Long-term treatment with azithromycin results in reduced ex-vivo inflammatory cytokine production in adults with cystic fibrosis. 16th Annual North American Cystic Fibrosis Conference, Louisiana, USA, 3-6 October, 2002. New York: Wiley-Liss. doi: 10.1002/ppul.70010  | 
              
| 
 2002 Conference Publication Long-term treatment with azithromycin results in reduced in vitro inflammatory cytokine production in adults with cystic fibrosisBowler, S. D., Seeney, S., Walmsley, K., Wolter, J.M., Bell, S. C. and McCormack, J. G. (2002). Long-term treatment with azithromycin results in reduced in vitro inflammatory cytokine production in adults with cystic fibrosis. TSANZ Annual Scientific Meeting, Cairns, Queensland, 22-27 March, 2002. Carlton: Blackwell Asia. doi: 10.1111/j.1440-1843.2004.supp_1.x  | 
              
| 
 2002 Conference Publication Portrait of the cystic fibrosis (CF) patient in Australia and New Zealand (NZ) in 1999Cooper, P., McKay, K., Bobosevich, Z. and Bell, S. (2002). Portrait of the cystic fibrosis (CF) patient in Australia and New Zealand (NZ) in 1999. TSANZ Annual Scientific Meeting, Cairns, 22-27 Mar, 2002. Carlton: Blackwell Asia.  | 
              
| 
 2002 Conference Publication Antibiotic desensitisation in adults with cystic fibrosisBurrows, J., Toon, M. and Bell, S. C. (2002). Antibiotic desensitisation in adults with cystic fibrosis. SHPA State Conference 2002 - Reducing risk: the cornerstone of hospital pharmacy, Brisbane, 1-3 Nov. 2002. Brisbane: SHPA Qld.  | 
              
| 
 2002 Conference Publication Cost of providing nutritional support for adult patients with cystif fibrosis (CF)McMillan, J., Matson, A., Matson, K. and Bell, S. (2002). Cost of providing nutritional support for adult patients with cystif fibrosis (CF). TSANZ Annual Scientific Meeting, Cairns, 22-27 Mar, 2002. Carlton: Blackwell Asia.  | 
              
| 
 2002 Journal Article Optimising nutrition in cystic fibrosisBell, S. C. and Shepherd, R. W. (2002). Optimising nutrition in cystic fibrosis. Journal of Cystic Fibrosis, 1 (2), 47-50. doi: 10.1016/S1569-1993(02)00031-0  | 
              
| 
 2002 Conference Publication Calcium homeostasis in patients with cystic fibrosisGreer, R., Buntain, H., Wainwright, C., Wong, J., Lewindon, P., Potter, J., Francis, P., O'Rourke, P., Munns, C., Batch, J. and Bell, S. (2002). Calcium homeostasis in patients with cystic fibrosis. TSANZ Annual Scientific Meeting, Cairns, QLD, Australia, 22-27 March 2002. Carlton, VIC, Australia: Blackwell Asia. doi: 10.1111/j.1440-1843.2004.supp_2.x  | 
              
| 
 2002 Journal Article Prevalence of complementary and alternative medicine use by adults with cystic fibrosisBurrows, J. A., Bajramovic, J. and Bell, S. C. (2002). Prevalence of complementary and alternative medicine use by adults with cystic fibrosis. Journal of Pharmacy Practice and Research, 32 (4), 320-323. doi: 10.1002/jppr2002324320  |